These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30975883)

  • 21. The parathyroid hormone receptorsome and the potential for therapeutic intervention.
    Mahon MJ
    Curr Drug Targets; 2012 Jan; 13(1):116-28. PubMed ID: 21777186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Mechanism of Ca
    Li M; Li M; Guo J
    J Chem Inf Model; 2022 Nov; 62(21):5110-5119. PubMed ID: 34464108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of PTH1R signaling by an ECD binding antibody results in inhibition of β-arrestin 2 coupling.
    Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
    Sci Rep; 2019 Oct; 9(1):14432. PubMed ID: 31594997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural characterization of the parathyroid hormone receptor domains determinant for ligand binding.
    Mierke DF; Mao L; Pellegrini M; Piserchio A; Plati J; Tsomaia N
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):721-3. PubMed ID: 17635133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mid-region of parathyroid hormone (1-34) serves as a functional docking domain in receptor activation.
    Wittelsberger A; Corich M; Thomas BE; Lee BK; Barazza A; Czodrowski P; Mierke DF; Chorev M; Rosenblatt M
    Biochemistry; 2006 Feb; 45(7):2027-34. PubMed ID: 16475791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding specificity of the ectodomain of the parathyroid hormone receptor.
    Drechsler N; Fröbel J; Jahreis G; Gopalswamy M; Balbach J; Bosse-Doenecke E; Rudolph R
    Biophys Chem; 2011 Mar; 154(2-3):66-72. PubMed ID: 21339037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmembrane residues together with the amino terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide.
    Turner PR; Mefford S; Bambino T; Nissenson RA
    J Biol Chem; 1998 Feb; 273(7):3830-7. PubMed ID: 9461563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.
    Gensure RC; Gardella TJ; Jüppner H
    Biochem Biophys Res Commun; 2005 Mar; 328(3):666-78. PubMed ID: 15694400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
    Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
    Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.
    Sneddon WB; Yang Y; Ba J; Harinstein LM; Friedman PA
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F1028-34. PubMed ID: 17107942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe.
    Carter PH; Liu RQ; Foster WR; Tamasi JA; Tebben AJ; Favata M; Staal A; Cvijic ME; French MH; Dell V; Apanovitch D; Lei M; Zhao Q; Cunningham M; Decicco CP; Trzaskos JM; Feyen JH
    Proc Natl Acad Sci U S A; 2007 Apr; 104(16):6846-51. PubMed ID: 17428923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors.
    Yin Y; de Waal PW; He Y; Zhao LH; Yang D; Cai X; Jiang Y; Melcher K; Wang MW; Xu HE
    J Biol Chem; 2017 Jun; 292(24):9865-9881. PubMed ID: 28356352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator.
    Li M; Bao Y; Xu R; Li M; Xi L; Guo J
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering a soluble parathyroid hormone GPCR mimetic.
    Audu CO; Plati JJ; Pellegrini M; Mierke DF
    Proteins; 2014 Jul; 82(7):1370-5. PubMed ID: 24375686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of a ligand-tethered parathyroid hormone receptor.
    Monticelli L; Mammi S; Mierke DF
    Biophys Chem; 2002 Feb; 95(2):165-72. PubMed ID: 11897155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational changes in the parathyroid hormone receptor associated with activation by agonist.
    Thomas BE; Woznica I; Mierke DF; Wittelsberger A; Rosenblatt M
    Mol Endocrinol; 2008 May; 22(5):1154-62. PubMed ID: 18258686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteolytic Cleavage of the Extracellular Domain Affects Signaling of Parathyroid Hormone 1 Receptor.
    Klenk C; Hommers L; Lohse MJ
    Front Endocrinol (Lausanne); 2022; 13():839351. PubMed ID: 35273573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of PTH1R signaling by an extracellular binding antibody.
    Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
    Vitam Horm; 2022; 120():109-132. PubMed ID: 35953107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
    Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
    Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
    Hoare SR; Usdin TB
    Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.